Management - Paron Biotech

Bruce Logan

Bruce Logan is the President and Director of Operations at Paron Biotech. Mr. Logan is responsible for all aspects of the business while maintaining particular interest in scale-up and new product manufacturing. Mr. Logan has been in the pharmaceutical manufacturing business for over 35 years from API production to finished dosage form. His expertise is in the conversion of Pilot Plant production to efficient commercial scale production. Mr. Logan’s contributions as a member of the Paron Biotech management team since 2000 have helped to double the output of some of Paron Biotech’s manufacturing processes as well as the design and construction of new facilities to meet the growing demand for commercial products. Prior to joining Paron Biotech, Mr. Logan was the Operations Manager at Sulzer Biologics in Golden, CO where he developed a manufacturing team to extract and isolate proteins. Mr. Logan also managed manufacturing activities at Hauser Chemical Research in the extraction and purification of novel compounds.

Ethan Jeremy

Ethan Jeremy is the Vice President and Director of Process Research and Development at Paron Biotech. He leads the process research and development activities at Paron Biotech concluding with new product manufacturing for both contract pharma and “in-house” active pharmaceutical ingredient (API) projects. Jeremy has accumulated over 23 years of industrial process R&D and manufacturing experience in both the fine chemical and pharmaceutical industries working initially for NSC Technologies (a division of Monsanto NutraSweet) followed by Great Lakes Fine Chemicals Division and Albany Molecular Research (AMRI) before joining Paron Biotech in 2008. Jeremy’s academic qualifications comprise 1st class honors degree in Applied Chemistry with professional experience and a PhD degree from the University of Salford in the United Kingdom with subsequent Postdoctoral research studies under Professor A. R. Katritzky at the University of Florida and then Professor T. C. Gallagher at the University of Bristol. Jeremy brings to Paron Biotech a sound scientific and scale-up background from both the fine chemical and pharmaceutical industries along with a solid comprehension of cGMP requirements for successful scale-up and manufacture at metric ton scale. Jeremy’s responsibilities at Paron Biotech include assisting his staff in defining robust and safely scalable processes for supplying API’s across all phases of pharmaceutical development, from discovery through preclinical, clinical trials, through process validation and commercialization. Jeremy has also been involved in DMF submissions for numerous API’s being developed by Paron Biotech as well as assisting clients in filing IND’s in early phase API process development activities.

Randy Mason

Randy Mason heads the Quality Assurance and Quality Control Departments of Paron Biotech and oversees the overall Regulatory Compliance program at the site. Randy started his career at Paron Biotech in 1986 and has served in various capacities within the company, including Quality Control, Production Engineering, Technical Product Management, and Project Management. Randy was appointed Director of Quality Assurance and Regulatory Affairs in 2001 after holding the position of Quality Assurance Manager since 1999. During this period, Randy has helped to implement modern and robust Quality Systems and cGMP compliance programs, and also facility renovation and improvement projects at Paron Biotech. He has been involved in two Pre-Approval Inspections, both resulting in FDA recommendations for product approval, as well as routine inspections by the FDA and DEA.

Randy’s background includes a degree in Manufacturing Engineering from Virginia Tech University, Pomona and a Certificate in Pharmaceutical Engineering from Cal State Fullerton. He is an ASQ Certified Quality Auditor (CQA 2001), and also Regulatory Affairs Certified (US-RAC 2002). He is a current member of ISPE, ASQ, and OCRA-DG.